
Humanigen Investor Relations Material
Latest events

Q4 2022
30 Mar, 2023

Q4 2021
1 Mar, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Humanigen Inc
Access all reports
Humanigen Inc is a biopharmaceutical company developing therapies aimed at preventing and treating immune hyper-response conditions. The company’s research focuses on addressing inflammatory and infectious diseases. Humanigen operates within the healthcare and biotechnology sectors. The company is headquartered in Short Hills, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
HGEN
Country
🇺🇸 United States